What is multiple myeloma?

Multiple myeloma is a cancer that starts in plasma cells. Plasma cells are a type of white blood cell that makes antibodies (also called immunoglobulins) to help the body fight infection.

Plasma cells are found mainly in the bone marrow but are also in some other tissues and organs. Bone marrow is the soft, spongy tissue inside most bones where different types of blood cells are made. Plasma cells in the bone marrow sometimes change and no longer grow or behave normally. These abnormal plasma cells begin to divide uncontrollably and make more abnormal plasma cells. These changes can lead to multiple myeloma (a cancer of the plasma cells) or a precancerous condition called monoclonal gammopathy of undetermined significance (MGUS). Precancerous means that the cells are not yet cancer but there is a higher chance these abnormal changes will become cancer. In some cases, MGUS can develop into multiple myeloma.

Multiple myeloma develops when there is a buildup of many abnormal plasma cells (called myeloma cells) in the bone marrow. This makes it hard for other blood cells in the bone marrow to develop and work normally. This can cause anemia and fatigue because there are fewer red blood cells. The buildup of myeloma cells can also upset the balance of certain minerals in the body. The myeloma cells make a substance that leads to bone damage and high levels of calcium in the blood. Myeloma cells also make abnormal proteins that can affect other organs such as the kidneys.

Myeloma cells can form tumours in bones (called plasmacytomas). If there is only one tumour in a bone, it is called a solitary plasmacytoma. When many plasmacytomas are found in the bones, the condition is called multiple myeloma. Plasmacytomas can also form outside of the bones. These tumours are called extramedullary plasmacytomas.

Diagram of plasma cell development
Diagram of plasma cell development

Expert review and references

  • American Cancer Society . Multiple myeloma . Atlanta, GA : American Cancer Society ; 2014 : https://www.cancer.org/.
  • Dispenzieri A, Lacy MQ, Kumar S . Multiple myeloma. Greer JP, Arber DA, Glader B, List AF, Means RT Jr, Paraskevas F, Rodgers GM, Foerster J, (eds.). Wintrobe's Clinical Hematology. 13th ed. Lippincott Williams & Wilkins; 2014: 98: 2046-2097.
  • Mushi NC, Anderson KC . Plasma cell neoplasms. DeVita VT Jr, Lawrence TS, & Rosenberg SA. Cancer: Principles and Practice of Oncology. 10th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2015: 112: 1682-1719.
  • Myeloma Canada. Multiple Myeloma Patient Handbook. Third ed. Kirkland, QC: Myeloma Canada; 2014.
  • National Cancer Institute. Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment PDQ®: Patient Version. National Cancer Institute; 2015: http://www.cancer.gov/cancertopics/pdq/treatment/myeloma/Patient.
  • Rajkumar SV, Kyle RA . Diagnosis and treatment of multiple myeloma. Wiernik PH, Goldman JM, Dutcher JP, Kyle RA (eds.). Neoplastic Diseases of the Blood. 5th ed. Springer; 2013: 33: 637-664.

The plasma cells

Multiple myeloma is a cancer of the plasma cells, a type of white blood cell. Learn more about the anatomy and physiology related to multiple myeloma.

Types of multiple myeloma

Multiple myeloma is the most common type of plasma cell cancer. Learn more about types of multiple myeloma, including smouldering, active and light chain myeloma.

Conditions related to multiple myeloma

There are conditions related to multiple myeloma. Learn more about osteosclerotic myeloma, Waldenstrom macroglobulinemia and other related conditions.

Monoclonal gammopathy of undetermined significance

MGUS is a precancerous condition and the most common plasma cell disorder. Over time, MGUS may develop into multiple myeloma. Learn more about MGUS.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.

1-888-939-3333 | cancer.ca | © 2024 Canadian Cancer Society